Literature DB >> 16870307

Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque.

Jodi L Downs1, Michael R Dunn, Erzsebet Borok, Marya Shanabrough, Tamas L Horvath, Steven G Kohama, Henryk F Urbanski.   

Abstract

Orexin neuropeptides regulate arousal state and excite the noradrenergic locus coeruleus (LC), so it is plausible that an age-related loss of orexin neurons and projections to the LC contributes to poor sleep quality in elderly humans and nonhuman primates. To test this hypothesis we examined orexin B-immunoreactivity in the lateral hypothalamic area (LHA) and the LC of male rhesus macaques (Macaca mulatta) throughout the life span. Orexin perikarya, localized predominantly in the LHA, showed identical distribution patterns irrespective of age. Similarly, orexin neuron number and serum orexin B concentrations did not differ with age. In contrast, orexin B-immunoreactive axon density in the LC of old animals was significantly lower than that observed in the young or adult animals. Furthermore, the age-related decline was associated with a significant decrease in tyrosine hydroxylase (TH) mRNA in the LC, despite no change in TH-immunoreactive neuron number. Taken together, these data suggest that age-related decreases in excitatory orexin innervation to the noradrenergic LC may contribute to the etiology of poor sleep quality in the elderly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16870307     DOI: 10.1016/j.neurobiolaging.2006.05.025

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  34 in total

1.  Age- and gender-specific changes of hypocretin immunopositive neurons in C57Bl/6 mice.

Authors:  Sara E Brownell; Bruno Conti
Journal:  Neurosci Lett       Date:  2010-02-01       Impact factor: 3.046

Review 2.  Role of circadian neuroendocrine rhythms in the control of behavior and physiology.

Authors:  Henryk F Urbanski
Journal:  Neuroendocrinology       Date:  2011-04-21       Impact factor: 4.914

3.  Lost in transition: aging-related changes in executive control by the medial prefrontal cortex.

Authors:  Marcelo S Caetano; Nicole K Horst; Linda Harenberg; Benjamine Liu; Amy F T Arnsten; Mark Laubach
Journal:  J Neurosci       Date:  2012-03-14       Impact factor: 6.167

4.  Reduction of the molecular chaperone binding immunoglobulin protein (BiP) accentuates the effect of aging on sleep-wake behavior.

Authors:  Nirinjini Naidoo; Jingxu Zhu; Raymond J Galante; Jie Lian; Ewa Strus; Amy Lee; Brendan T Keenan; Allan I Pack
Journal:  Neurobiol Aging       Date:  2018-04-30       Impact factor: 4.673

Review 5.  Orexin, stress, and anxiety/panic states.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; William A Truitt; Anantha Shekhar
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

6.  Glutamate receptor subunit expression in the rhesus macaque locus coeruleus.

Authors:  Nigel C Noriega; Vasilios T Garyfallou; Steven G Kohama; Henryk F Urbanski
Journal:  Brain Res       Date:  2007-08-09       Impact factor: 3.252

Review 7.  Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction.

Authors:  Coleman B Calva; Jim R Fadel
Journal:  Brain Res       Date:  2018-08-24       Impact factor: 3.252

Review 8.  Energy expenditure and aging.

Authors:  Todd M Manini
Journal:  Ageing Res Rev       Date:  2009-08-19       Impact factor: 10.895

Review 9.  Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses.

Authors:  Amy F T Arnsten; Min J Wang; Constantinos D Paspalas
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.